Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Perez

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Neoplasia (New York, N.Y.)|November 19, 2004
The novel highly lipophilic topoisomerase I inhibitor DB67 is effective in the treatment of liver metastases of murine CT-26 colon carcinomaLluis A Lopez-Barcons, Junhong Zhang, Gunching Siriwitayawan, et al.
Current Drug Targets|October 21, 2009
Intercalation of erlotinib and pemetrexed in the treatment of non-small cell lung cancerTianhong Li, Primo N Lara, Philip C Mack, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
The BCL2-family of protein ligands as cancer drugs: the next generation of therapeuticsWenJing Liu, Anca Bulgaru, Missak Haigentz, et al.
Brain Research. Molecular Brain Research|December 14, 2002
1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult ratsBegoña Sanchez, Elena Lopez-Martin, Carmen Segura, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 6, 2015
Microarchitecture for a three-dimensional wrinkled surface platformMinggan Li, Navid Hakimi, Roman Perez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2013
The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinibYiyu Zou, Yi-He Ling, Juan Sironi, et al.
Molecular Pharmacology|April 26, 2007
Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell linesYi-He Ling, Tianhong Li, Ziqiang Yuan, et al.
Cancer Research|March 15, 2008
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximabMinaxi Jhawer, Sanjay Goel, Andrew J Wilson, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 2, 2019
Enhanced osteoconductivity on electrically charged titanium implants treated by physicochemical surface modifications methodsMarc Fernández-Yagüe, Roman Perez Antoñanzas, Joan Josep Roa, et al.
International Journal of Public Health|October 15, 2020
The role of burden of disease assessment in tracking progress towards achieving WHO global air quality guidelinesDimitris Evangelopoulos, Roman Perez-Velasco, Heather Walton, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Neoplasia (New York, N.Y.)|November 19, 2004
The novel highly lipophilic topoisomerase I inhibitor DB67 is effective in the treatment of liver metastases of murine CT-26 colon carcinomaLluis A Lopez-Barcons, Junhong Zhang, Gunching Siriwitayawan, et al.
Current Drug Targets|October 21, 2009
Intercalation of erlotinib and pemetrexed in the treatment of non-small cell lung cancerTianhong Li, Primo N Lara, Philip C Mack, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
The BCL2-family of protein ligands as cancer drugs: the next generation of therapeuticsWenJing Liu, Anca Bulgaru, Missak Haigentz, et al.
Brain Research. Molecular Brain Research|December 14, 2002
1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult ratsBegoña Sanchez, Elena Lopez-Martin, Carmen Segura, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 6, 2015
Microarchitecture for a three-dimensional wrinkled surface platformMinggan Li, Navid Hakimi, Roman Perez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2013
The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinibYiyu Zou, Yi-He Ling, Juan Sironi, et al.
Molecular Pharmacology|April 26, 2007
Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell linesYi-He Ling, Tianhong Li, Ziqiang Yuan, et al.
Cancer Research|March 15, 2008
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximabMinaxi Jhawer, Sanjay Goel, Andrew J Wilson, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 2, 2019
Enhanced osteoconductivity on electrically charged titanium implants treated by physicochemical surface modifications methodsMarc Fernández-Yagüe, Roman Perez Antoñanzas, Joan Josep Roa, et al.
International Journal of Public Health|October 15, 2020
The role of burden of disease assessment in tracking progress towards achieving WHO global air quality guidelinesDimitris Evangelopoulos, Roman Perez-Velasco, Heather Walton, et al.
Pageof 14